Search for Clinical Trial Results

Carcinoma, Merkel Cell - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200) Condition: Carcinoma, Merkel Cell Date: 2014-06-02 Interventions: Drug: Avelumab Avelumab will be administered at a dose of 10 milligram per kilogram (mg/kg) as 1-hour in |
Recruiting |
Study Name: MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma Condition: Merkel Cell Carcinoma Date: 2015-07-28 Interventions: Drug: MLN0128 Investigational mTOR kinase inhibitor |
Recruiting |
Study Name: F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma Condition: Merkel Cell Carcinoma Date: 2014-01-31 Interventions:
|
Active, not recruiting |
Study Name: A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma Condition: Merkel Cell Carcinoma Date: 2014-01-10 Interventions: Biological: GLA-SE Glucopyranosyl Lipid A in Stable Emulsion |
Recruiting |
Study Name: Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With 3 mg/kg BW Ipilimumab (Yervoy®) Versus Observation Condition: Merkel Cell Carcinoma Date: 2014-06-20 Interventions: Drug: Ipilimumab adjuvant treatment of completely resected Merkel cell carcinoma |
Recruiting |
Study Name: Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues Condition: Carcinoma, Merkel Cell Date: 2015-01-13 Interventions: Drug: Lanreotide Other Name: Somatuline |
Available |
Study Name: Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC) Condition: Metastatic Merkel Cell Carcinoma Date: 2017-03-20 Interventions: Drug: Avelumab Avelumab should be administered intravenously as per the recommended dose. Administration |
Withdrawn |
Study Name: Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma Condition: Merkel Cell Carcinoma Date: 2013-07-28 Interventions: Drug: Ipilimumab Ipilimumab is a recombinant, human monoclonal antibody that binds to CTLA-4. It is comm |
Completed |
Study Name: IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer Condition: Merkel Cell Carcinoma Date: 2011-09-23 Interventions:
|
Terminated |
Study Name: Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma Condition:
|